Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2011-01-11
2011-01-11
Saoud, Christine J (Department: 1647)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C530S300000, C530S326000
Reexamination Certificate
active
07867976
ABSTRACT:
Epitopic fragments of Nogo, including Nogo 45-66, elicit a specific and strong T cell response, and a B cell response. T cells reactive to Nogo antigens are capable of ameliorating ongoing disease, which may be induced with other antigens. The present invention provides compositions and methods for the identification and use of Nogo epitopic fragments in the treatment of immune related disease.
REFERENCES:
patent: 7119165 (2006-10-01), Strittmatter
patent: 7560102 (2009-07-01), Eisenbach-Schwartz et al.
Fontoura, Paulo, et al., “Immunity to the Extracellular Domain of Nogo-A Modulates Experimental Autoimmune Encephalomyelitis”,The Journal of Immunology, Dec. 2004, vol. 173, No. 11, pp. 6981-6992.
Hauben, Ehud, et al., “Vaccination with a Nogo-A-derived peptide after incomplete spinal-cord injury promotes recovery via a T-cell-mediated neuroprotective response: Comparison with other myelin antigens”, Proc. Natl. Acad. Sci. USA. vol. 98, No. 26, pp. 15173-15178, Dec. 2001.
Fontoura Paulo
Garren Hideki
Steinman Lawrence
Bozicevic Field & Francis LLP
Lockard Jon M
Saoud Christine J
Sherwood Pamela J.
The Board of Trustees of the Leland Stanford Junior University
LandOfFree
Nogo epitopic fragments for modulating immune response does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nogo epitopic fragments for modulating immune response, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nogo epitopic fragments for modulating immune response will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2668504